


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app29.us.archive.org';v.server_ms=629;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Nasopharyngeal cancer treatment. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712204003im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712204003im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712204003im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712204003im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712204003/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712204003im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712204003cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712204003js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712204003if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204003/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712204003if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712204003/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712204003/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712204003/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712204003/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712204003/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712204003/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712204003/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712204003/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712204003/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712204003/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712204003/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712204003/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712204003/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712204003/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712204003/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712204003/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712204003/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712204003/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712204003/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712204003/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010386</li>
            <li>2013 Dec
            </li>            
                                </ul>
        <div>
                <h1>Nasopharyngeal cancer treatment.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712204003/https://www.guideline.gov/search?f_Guideline_Developer_String=CancerControl%20Alberta&amp;fLockTerm=CancerControl%2BAlberta">CancerControl Alberta</a></li>
                        <li>   
                                <a id="2278" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Alberta Provincial Head and Neck Tumour Team. Nasopharyngeal cancer treatment. Edmonton (Alberta): CancerControl Alberta; 2013 Dec. 17 p.&nbsp;(Clinical practice guideline; no. HN-003).&nbsp; [36 references]</td></tr></table>                    <p><a href="/web/20180712204003/https://www.guideline.gov/Home/Disclaimer?id=48140&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fwww.albertahealthservices.ca%252fassets%252finfo%252fhp%252fcancer%252fif-hp-cancer-guide-hn003-nasopharyngeal.pdf">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204003im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712204003/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%20%2865%20to%2079%20years%29&amp;fLockTerm=Aged%2B%2865%2Bto%2B79%2Byears%29">Aged (65 to 79 years)</a></li>                      
                        <li><a href="/web/20180712204003/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%2C%2080%20and%20over&amp;fLockTerm=Aged%252c%2B80%2Band%2Bover">Aged, 80 and over</a></li>                      
                        <li><a href="/web/20180712204003/https://www.guideline.gov/search?f_Age_of_Target_Population=Middle%20Age%20%2845%20to%2064%20years%29&amp;fLockTerm=Middle%2BAge%2B%2845%2Bto%2B64%2Byears%29">Middle Age (45 to 64 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712204003/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_ICD9CM_CUI=C0750862&amp;fLockTerm=Dental+examination">Dental examination</a>
 (89.31), <a href="/web/20180712204003/https://www.guideline.gov/search?f_ICD9CM_CUI=C0031809&amp;fLockTerm=General+physical+examination">General physical examination</a>
 (89.7), <a href="/web/20180712204003/https://www.guideline.gov/search?f_ICD9CM_CUI=C0018786&amp;fLockTerm=Hearing+examination%2c+not+otherwise+specified">Hearing examination, not otherwise specified</a>
 (95.42), <a href="/web/20180712204003/https://www.guideline.gov/search?f_ICD9CM_CUI=C0018786&amp;fLockTerm=Hearing+examination%2c+not+otherwise+specified">Hearing examination, not otherwise specified</a>
 (95.47)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0079083&amp;fLockTerm=Carboplatin">Carboplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0436307&amp;fLockTerm=Chemoradiotherapy">Chemoradiotherapy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C3178761&amp;fLockTerm=Chemoradiotherapy%2c+Adjuvant">Chemoradiotherapy, Adjuvant</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0008838&amp;fLockTerm=Cisplatin">Cisplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0008976&amp;fLockTerm=Clinical+Trials+as+Topic">Clinical Trials as Topic</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0014243&amp;fLockTerm=Endoscopes">Endoscopes</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0014245&amp;fLockTerm=Endoscopy">Endoscopy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0016360&amp;fLockTerm=Fluorouracil">Fluorouracil</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0016911&amp;fLockTerm=Gadolinium">Gadolinium</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0018671&amp;fLockTerm=Head+and+Neck+Neoplasms">Head and Neck Neoplasms</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0018786&amp;fLockTerm=Hearing+Tests">Hearing Tests</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0027439&amp;fLockTerm=Nasopharyngeal+Neoplasms">Nasopharyngeal Neoplasms</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0027627&amp;fLockTerm=Neoplasm+Metastasis">Neoplasm Metastasis</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0027643&amp;fLockTerm=Neoplasm+Recurrence%2c+Local">Neoplasm Recurrence, Local</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0028708&amp;fLockTerm=Nutrition+Assessment">Nutrition Assessment</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0031809&amp;fLockTerm=Physical+Examination">Physical Examination</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C1522449&amp;fLockTerm=Radiotherapy">Radiotherapy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C1512814&amp;fLockTerm=Radiotherapy%2c+Intensity-Modulated">Radiotherapy, Intensity-Modulated</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0936234&amp;fLockTerm=Tomography+Scanners%2c+X-Ray+Computed">Tomography Scanners, X-Ray Computed</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MSH_CUI=C0040405&amp;fLockTerm=Tomography%2c+X-Ray+Computed">Tomography, X-Ray Computed</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0079083&amp;fLockTerm=Carboplatin">Carboplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0436307&amp;fLockTerm=Chemoradiotherapy">Chemoradiotherapy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0008838&amp;fLockTerm=Cisplatin">Cisplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0008976&amp;fLockTerm=Clinical+Trials">Clinical Trials</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0936234&amp;fLockTerm=Computed+Tomography+Scanning+Systems">Computed Tomography Scanning Systems</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0750862&amp;fLockTerm=Dental+examination">Dental examination</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0014243&amp;fLockTerm=Endoscopes">Endoscopes</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0014245&amp;fLockTerm=Endoscopy+(procedure)">Endoscopy (procedure)</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C2239107&amp;fLockTerm=examination+of+head">examination of head</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0016360&amp;fLockTerm=Fluorouracil">Fluorouracil</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C1522577&amp;fLockTerm=follow-up">follow-up</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0589120&amp;fLockTerm=Follow-up+status">Follow-up status</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0016911&amp;fLockTerm=Gadolinium">Gadolinium</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0018671&amp;fLockTerm=Head+and+Neck+Neoplasms">Head and Neck Neoplasms</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0018786&amp;fLockTerm=Hearing+Tests">Hearing Tests</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0027627&amp;fLockTerm=Neoplasm+Metastasis">Neoplasm Metastasis</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0028708&amp;fLockTerm=Nutrition+Assessment">Nutrition Assessment</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0031809&amp;fLockTerm=physical+examination">physical examination</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0302617&amp;fLockTerm=Radiographic-therapeutic+unit+device">Radiographic-therapeutic unit device</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C1522449&amp;fLockTerm=Therapeutic+radiology+procedure">Therapeutic radiology procedure</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_MTH_CUI=C0040405&amp;fLockTerm=X-Ray+Computed+Tomography">X-Ray Computed Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0005558&amp;fLockTerm=biopsies">biopsies</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0079083&amp;fLockTerm=carboplatin">carboplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0008838&amp;fLockTerm=cisplatin">cisplatin</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0040405&amp;fLockTerm=computed+tomography">computed tomography</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0014245&amp;fLockTerm=endoscopy">endoscopy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0016360&amp;fLockTerm=fluorouracil">fluorouracil</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C1512814&amp;fLockTerm=intensity-modulated+radiation+therapy">intensity-modulated radiation therapy</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C0024485&amp;fLockTerm=magnetic+resonance+imaging">magnetic resonance imaging</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_PDQ_CUI=C1522449&amp;fLockTerm=radiation+therapy">radiation therapy</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0028708&amp;fLockTerm=Assessment+of+nutritional+status">Assessment of nutritional status</a>
 (1759002), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0028708&amp;fLockTerm=Assessment+of+nutritional+status">Assessment of nutritional status</a>
 (310243009), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (252575000), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (32921008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (398171003), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018786&amp;fLockTerm=Auditory+testing">Auditory testing</a>
 (398280008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (129314006), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (86273004), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0396352&amp;fLockTerm=Biopsy+of+nasopharynx">Biopsy of nasopharynx</a>
 (232539009), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0079083&amp;fLockTerm=Carboplatin">Carboplatin</a>
 (108759002), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0079083&amp;fLockTerm=Carboplatin">Carboplatin</a>
 (386905002), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1531652&amp;fLockTerm=Chest+imaging">Chest imaging</a>
 (413815006), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0008838&amp;fLockTerm=Cisplatin">Cisplatin</a>
 (387318005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0008838&amp;fLockTerm=Cisplatin">Cisplatin</a>
 (57066004), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0008976&amp;fLockTerm=Clinical+trial">Clinical trial</a>
 (110465008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040405&amp;fLockTerm=Computerized+axial+tomography">Computerized axial tomography</a>
 (77477000), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (385420005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (407935004), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014243&amp;fLockTerm=Endoscope">Endoscope</a>
 (37270008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014245&amp;fLockTerm=Endoscopy">Endoscopy</a>
 (423827005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1144728&amp;fLockTerm=Evaluation+of+oral+and+pharyngeal+swallowing+function">Evaluation of oral and pharyngeal swallowing function</a>
 (440363007), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0558588&amp;fLockTerm=Examination+under+anesthesia">Examination under anesthesia</a>
 (274392008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0016360&amp;fLockTerm=Fluorouracil">Fluorouracil</a>
 (3127006), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0016360&amp;fLockTerm=Fluorouracil">Fluorouracil</a>
 (387172005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0589120&amp;fLockTerm=Follow-up+status">Follow-up status</a>
 (308273005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0016911&amp;fLockTerm=Gadolinium">Gadolinium</a>
 (58281002), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1512814&amp;fLockTerm=Intensity+modulated+radiation+therapy">Intensity modulated radiation therapy</a>
 (441799006), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (113091000), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (312250003), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0336660&amp;fLockTerm=Magnetic+resonance+imaging+unit">Magnetic resonance imaging unit</a>
 (90003000), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018671&amp;fLockTerm=Neoplasm+of+head+and+neck">Neoplasm of head and neck</a>
 (255055008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0027439&amp;fLockTerm=Neoplasm+of+nasopharynx">Neoplasm of nasopharynx</a>
 (126680004), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0475092&amp;fLockTerm=Palliative+course+of+radiotherapy">Palliative course of radiotherapy</a>
 (168528006), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (302199004), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (5880005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (81375008), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (363678002), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (82918005), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1522449&amp;fLockTerm=Radiation+oncology+AND%2fOR+radiotherapy">Radiation oncology AND/OR radiotherapy</a>
 (108290001), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1522449&amp;fLockTerm=Radiation+oncology+AND%2fOR+radiotherapy">Radiation oncology AND/OR radiotherapy</a>
 (53438000), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0302617&amp;fLockTerm=Radiographic-therapeutic+unit">Radiographic-therapeutic unit</a>
 (10850003), <a href="/web/20180712204003/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1321019&amp;fLockTerm=Swallowing+status">Swallowing status</a>
 (405035003)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_SPN_CUI=C0014243&amp;fLockTerm=ENDOSCOPE+AND%2fOR+ACCESSORIES">ENDOSCOPE AND/OR ACCESSORIES</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_SPN_CUI=C0336660&amp;fLockTerm=SYSTEM%2c+NUCLEAR+MAGNETIC+RESONANCE+IMAGING">SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING</a>
, <a href="/web/20180712204003/https://www.guideline.gov/search?f_SPN_CUI=C0936234&amp;fLockTerm=SYSTEM%2c+X-RAY%2c+TOMOGRAPHY%2c+COMPUTED">SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
 (16-573), <a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C0014243&amp;fLockTerm=Endoscopes">Endoscopes</a>
 (20-475), <a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C0302617&amp;fLockTerm=Radiotherapy+Systems">Radiotherapy Systems</a>
 (13-279), <a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C0936234&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography">Scanning Systems, Computed Tomography</a>
 (13-469), <a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C1139717&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography%2fPositron+Emission+Tomography">Scanning Systems, Computed Tomography/Positron Emission Tomography</a>
 (20-161), <a href="/web/20180712204003/https://www.guideline.gov/search?f_UMD_CUI=C0336660&amp;fLockTerm=Scanning+Systems%2c+Magnetic+Resonance+Imaging">Scanning Systems, Magnetic Resonance Imaging</a>
 (16-260)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/downloadcontent/ngc-10386?contentType=pdf" class="pdf">.PDF 90.2 kb</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/downloadcontent/ngc-10386?contentType=word" class="word">Word Document 283.8 kb</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/downloadcontent/ngc-10386?contentType=xml" class="xml">.XML 33.1 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204003/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/48140/nasopharyngeal-cancer-treatment" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204003/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/48140/nasopharyngeal-cancer-treatment" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712204003/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/48140/nasopharyngeal-cancer-treatment&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712204003/mailto:/?Subject=AHRQ: Nasopharyngeal cancer treatment.&amp;body=https://www.guideline.gov/summaries/summary/48140/nasopharyngeal-cancer-treatment" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Nasopharyngeal cancer treatment. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Dec 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140">RefWorks</a></li>
                            <li><a href="/web/20180712204003/https://www.guideline.gov/summaries/citedownload/48140?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="48140" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The Alberta Provincial Head and Neck Tumour Team have adopted the recommendations of the National Comprehensive Cancer Network (NCCN), with modifications to fit the Alberta context (see the "Adaptation" field).</p>
<ol style="list-style-type: decimal;" start="1">
    <li><strong>Diagnosis and baseline investigations</strong>. The following investigations are recommended at diagnosis for all patients with suspected or confirmed early stage nasopharyngeal cancer (NPC):
    <ul style="list-style-type: disc;">
        <li>Complete head and neck examination </li>
        <li>Nasopharyngeal exam and biopsy </li>
        <li>Chest imaging </li>
        <li>Magnetic resonance imaging (MRI) with gadolinium of nasopharynx and base of skull to clavicles and/or computed tomography (CT) with contrast </li>
        <li>Positron emission tomography-computed tomography (PET-CT), as indicated; especially for nonkeratinizing histology, endemic phenotype, N2&ndash;3 disease, or stage III&ndash;IV disease </li>
        <li>Examination under anesthesia with endoscopy, as indicated </li>
        <li>Dental evaluation </li>
        <li>Nutrition, speech and swallowing evaluation/therapy and audiogram </li>
    </ul>
    </li>
    <li><strong>Treatment options</strong>. Patient participation in clinical trials is recommended. For standard treatment, all cases should be presented and discussed at a multidisciplinary Tumour Board to decide the best treatment option for each patient.
    <p><strong><em>Early-stage (T1, N0, M0)</em></strong>: Definitive radiotherapy (RT) to the nasopharynx and elective RT to the neck is recommended.</p>
    <ul style="list-style-type: disc;">
        <li>Primary:
        <ul style="list-style-type: disc;">
            <li>Total dose: 66&ndash;70 Gy </li>
            <li>Conventional fraction dose: 2.0&ndash;2.2 Gy </li>
            <li>Daily Monday&ndash;Friday in 6&ndash;7 weeks </li>
        </ul>
        </li>
        <li>Neck:
        <ul style="list-style-type: disc;">
            <li>Uninvolved nodal stations: 54&ndash;60 Gy </li>
            <li>Conventional fraction dose: 1.6&ndash;2.0 Gy </li>
        </ul>
        </li>
    </ul>
    <p>Intensity-modulated radiation therapy (IMRT) should be used to reduce critical structure doses to acceptable levels.</p>
    <p>Please see the early-stage treatment algorithm in the original guideline document.</p>
    <p><strong><em>Advanced-stage (T1, N1&ndash;3; T2&ndash;4, Any N, M0)</em></strong>: Concurrent chemoradiotherapy (chemoRT) with cisplatin is recommended. Adjuvant chemotherapy using platinum (cisplatin or carboplatin)/5-fluoruracil (5-FU) can be considered following primary treatment. The choice of chemotherapy should be individualized based on patient characteristics (performance status and goals of therapy). Where there is clinical evidence of residual disease in the neck, neck dissection is recommended, if feasible.</p>
    <p>Please see the advanced-stage treatment algorithm in the original guideline document.</p>
    <p><strong><em>Distant metastatic disease (Any T, Any N, M1)</em></strong>: All treatment of patients with distant metastatic disease is palliative in nature. If available, patients should consider participating in a clinical trial. Palliative RT can be considered in select cases. In patients with good performance status, palliative chemotherapy may be considered. Referral to palliative care services can be offered to patients.</p>
    <p>Please see the distant metastatic disease treatment algorithm in the original guideline document.</p>
    <p><em><strong>Recurrent or persistent disease</strong></em>: Restaging should be done to assess local, regional and distant disease. Biopsy of recurrent lesion(s) is recommended, as clinically indicated. Treatment should be individualized based on patient performance status and extent of disease.</p>
    <p>Treatment options include:</p>
    <ul style="list-style-type: disc;">
        <li>Salvage nasopharyngectomy, or </li>
        <li>Re-irradiation with brachytherapy, and/or </li>
        <li>Stereotactic guided treatments </li>
    </ul>
    <p>Please see the recurrent or persistent disease treatment algorithm in the original guideline document.</p>
    </li>
</ol>
<ol style="list-style-type: decimal;" start="3">
    <li><strong>Follow-up and surveillance</strong>: The following schedule should be taken into account to manage complications related to treatment, to detect disease recurrence and/or the development of new disease:
    <ul style="list-style-type: disc;">
        <li>Head and neck examination (note that the ranges are based on risk of relapse, second primaries, treatment sequelae, and toxicities):
        <ul style="list-style-type: disc;">
            <li>Year 1, every 1&ndash;3 months </li>
            <li>Year 2, every 2&ndash;6 months </li>
            <li>Year 3&ndash;5, every 4&ndash;8 months </li>
            <li>After 5 years, annually, as clinically indicated </li>
        </ul>
        </li>
        <li>Post-treatment baseline imaging of primary and neck, if treated, within 6 months of treatment for T3&ndash;4 or N2&ndash;3 disease only; further reimaging, as indicated </li>
        <li>Annual thyroid-stimulating hormone (TSH) screening up to 5 years </li>
        <li>Speech/swallowing assessment at 6 and 12 months post-RT; additional assessment and rehabilitation, as clinically indicated </li>
        <li>Hearing evaluation and rehabilitation, as clinically indicated </li>
        <li>Follow-up with a registered dietitian to evaluate nutritional status and until the patient achieves a nutritionally stable baseline </li>
        <li>Routine hospital-based dental follow-up and evaluation up to 3 years </li>
    </ul>
    </li>
</ol></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>The following algorithms are provided in the original guideline document:</p>
<ul style="list-style-type: disc;">
    <li>Early-stage (T1, N0, M0) </li>
    <li>Advanced-stage (T1, N1&ndash;3, T2&ndash;4, Any N, M0 and Any T, N, M1) </li>
    <li>Recurrent or Persistent Disease </li>
</ul></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Nasopharyngeal cancer (NPC) </p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Nutrition</p>
                    <p>Oncology</p>
                    <p>Otolaryngology</p>
                    <p>Radiation Oncology</p>
                    <p>Radiology</p>
                    <p>Speech-Language Pathology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Allied Health Personnel</p>
                    <p>Dentists</p>
                    <p>Dietitians</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Speech-Language Pathologists</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To outline treatment recommendations for patients with nasopharyngeal cancer (NPC)</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Adults over the age of 18 years with nasopharyngeal cancer (NPC)</p>
<p class="Note"><strong>Note</strong>: Different principles may apply to pediatric patients.</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Diagnosis/Evaluation</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Complete head and neck examination </li>
    <li>Nasopharyngeal exam and biopsy </li>
    <li>Chest imaging </li>
    <li>Magnetic resonance imaging (MRI) with gadolinium of nasopharynx and base of skull to clavicles and/or computed tomography (CT) with contrast </li>
    <li>Positron emission tomography-computed tomography (PET-CT), as indicated </li>
    <li>Examination under anesthesia with endoscopy, as indicated </li>
    <li>Dental evaluation </li>
    <li>Nutrition, speech and swallowing evaluation/therapy and audiogram </li>
</ol>
<p><strong>Treatment/Management</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Participation in clinical trials </li>
    <li>Radiotherapy </li>
    <li>Intensity-modulated radiation therapy (IMRT) </li>
    <li>Concurrent chemoradiotherapy with cisplatin </li>
    <li>Adjuvant chemotherapy using platinum (cisplatin or carboplatin)/5-fluoruracil [5-FU]) </li>
    <li>Palliative radiotherapy or chemotherapy for distant metastases </li>
    <li>Treatment of recurrent or persistent disease </li>
    <li>Follow-up and surveillance </li>
</ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Survival rates (overall, progression-free, relapse-free, metastasis-free) </li>
    <li>Recurrence rates </li>
    <li>Quality of life </li>
    <li>Toxicity and complications of treatment </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Research Questions</strong></p>
<p>Specific research questions to be addressed by the guideline document were formulated by the guideline lead(s) and Knowledge Management (KM) Specialist using the PICO question format (patient or population, intervention, comparisons, outcomes).</p>
<p><strong>Guideline Questions</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>What diagnostic and baseline investigations are recommended for patients with suspected or confirmed nasopharyngeal cancer (NPC)? </li>
    <li>What are the recommended treatment options for NPC? </li>
    <li>What is the recommended follow-up after treatment for NPC? </li>
</ol>
<p><strong>Search Strategy</strong></p>
<p>PubMed, MEDLINE and Cochrane Database of Systematic Reviews were searched from 2000 to April 5, 2013 for literature on the treatment of NPC. The search term <em>nasopharyngeal neoplasm</em> (MeSH) was used. Results were limited to phase III clinical trials, comparative studies, controlled clinical trials, guidelines, meta-analyses, multicenter studies, practice guidelines, randomized controlled trials and systematic reviews involving human subjects (19+ years) and published in English. Although phase II studies may be referenced in the discussion section, only phase III randomized studies and meta-analyses were considered for the literature search and review.</p>
<p>The National Guideline Clearinghouse and Standards and Guidelines Evidence (SAGE) Directory of Cancer Guidelines were also searched from 2008 to April 5, 2013 for guidelines on NPC.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Not stated</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Evidence was selected and reviewed by a working group comprised of members from the Alberta Provincial Head and Neck Tumour Team and a Knowledge Management (KM) Specialist from the Guideline Utilization Resource Unit (GURU). A detailed description of the methodology followed during the guideline development process can be found in the GURU Handbook (see the "Availability of Companion Documents" field).</p>
<p><strong>Evidence Tables</strong></p>
<p>Evidence tables containing the first author, year of publication, patient group/stage of disease, methodology, and main outcomes of interest are assembled using the studies identified in the literature search. Existing guidelines on the topic are assessed by the KM Specialist using portions of the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument (<a href="/web/20180712204003/https://www.guideline.gov/Home/Disclaimer?id=48140&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.agreetrust.org" title="AGREE Trust Web site">http://www.agreetrust.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204003im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>) and those meeting the minimum requirements are included in the evidence document. Due to limited resources, GURU does not regularly employ the use of multiple reviewers to rank the level of evidence; rather, the methodology portion of the evidence table contains the pertinent information required for the reader to judge for himself the quality of the studies.</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Formulating Recommendations</strong></p>
<p>The working group members formulated the guideline recommendations based on the evidence synthesized by the Knowledge Management (KM) Specialist during the planning process, blended with expert clinical interpretation of the evidence. As detailed in the Guideline Utilization Resource Unit Handbook (see the "Availability of Companion Documents" field), the working group members may decide to adopt the recommendations of another institution without any revisions, adapt the recommendations of another institution or institutions to better reflect local practices, or develop their own set of recommendations by adapting some, but not all, recommendations from different guidelines.</p>
<p>The degree to which a recommendation is based on expert opinion of the working group and/or the Provincial Tumour Team members is explicitly stated in the guideline recommendations. Similar to the American Society of Clinical Oncology (ASCO) methodology for formulating guideline recommendations, the Guideline Utilization Resource Unit (GURU) does not use formal rating schemes for describing the strength of the recommendations, but rather describes, in conventional and explicit language, the type and quality of the research and existing guidelines that were taken into consideration when formulating the recommendations.</p>
<p>For the current guideline, the Alberta Provincial Head and Neck Tumour Team reviewed the recommendations of several different guidelines, including those from the European Society for Medical Oncology, the Spanish Society of Medical Oncology and the National Comprehensive Cancer Network (NCCN). The Alberta Provincial Head and Neck Tumour Team have adopted the recommendations of the NCCN, with modifications to fit the Alberta context.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>This guideline was reviewed and endorsed by the Alberta Provincial Head and Neck Tumour Team, which is comprised of over 150 health care professionals from various disciplines.</p>
<p>When the draft guideline document has been completed, revised, and reviewed by the Knowledge Management Specialist and the working group members, it is sent to all members of the Provincial Tumour Team for review and comment. This step ensures that those intended to use the guideline have the opportunity to review the document and identify potential difficulties for implementation before the guideline is finalized. Depending on the size of the document, and the number of people it is sent to for review, a deadline of one to two weeks will usually be given to submit any feedback. Ideally, this review will occur prior to the annual Provincial Tumour Team meeting, and a discussion of the proposed edits will take place at the meeting. The working group members will then make final revisions to the document based on the received feedback, as appropriate. Once the guideline is finalized, it will be officially endorsed by the Provincial Tumour Team Lead and the Executive Director of Provincial Tumour Programs.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The Alberta Provincial Head and Neck Tumour Team adopted the recommendations of the National Comprehensive Cancer Network (NCCN), with modifications to fit the Alberta context (see the "Adaptation" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Appropriate nasopharyngeal cancer (NPC) treatment</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Complications and toxicity related to treatment, including xerostomia, leukopenia/neutropenia, nausea/vomiting, and mucositis</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The recommendations contained in this guideline are a consensus of the Alberta Provincial Head and Neck Tumour Team and are a synthesis of currently accepted approaches to management, derived from a review of relevant scientific literature. Clinicians applying these guidelines should, in consultation with the patient, use independent medical judgment in the context of individual clinical circumstances to direct care. </li>
    <li>These guidelines should be applied in the context of the recommendations outlined in CancerControl Alberta guideline <a href="/web/20180712204003/https://www.guideline.gov/Home/Disclaimer?id=48140&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.albertahealthservices.ca%2fassets%2finfo%2fhp%2fcancer%2fif-hp-cancer-guide-hn001-organization.pdf" title="Alberta Health Services Web site">The Organization and Delivery of Healthcare Services for Head and Neck Cancer Patients</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204003im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Present the guideline at the local and provincial tumour team meetings and weekly rounds. </li>
    <li>Post the guideline on the Alberta Health Services Web site. </li>
    <li>Send an electronic notification of the new guideline to all members of CancerControl Alberta. </li>
</ul></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Clinical Algorithm</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>End of Life Care</p>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Alberta Provincial Head and Neck Tumour Team. Nasopharyngeal cancer treatment. Edmonton (Alberta): CancerControl Alberta; 2013 Dec. 17 p.&nbsp;(Clinical practice guideline; no. HN-003).&nbsp; [36 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>The Alberta Provincial Head and Neck Tumour Team adopted the recommendations from the following source, with modifications to fit the Alberta context: National Comprehensive Cancer Network. Head and neck cancers: version I.2013. 2013; Available at: <a href="/web/20180712204003/https://www.guideline.gov/Home/Disclaimer?id=48140&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.nccn.org%2fprofessionals%2fphysician_gls%2fpdf%2fhead-and-neck.pdf" title="NCCN Web site">http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204003im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2013 Dec</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>CancerControl Alberta - State/Local Government Agency [Non-U.S.]</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>CancerControl Alberta</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Alberta Provincial Head and Neck Tumour Team</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p>Members of the Alberta Provincial Head and Neck Tumour Team include medical oncologists, radiation oncologists, head and neck surgeons, head and neck reconstructive surgeons, oral and maxillofacial surgeons, dentists, neuroradiologists, nurses, speech and language pathologists, pathologists, pharmacists, and other allied health professionals.</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Participation of members of the Alberta Provincial Head and Neck Tumour Team in the development of this guideline has been voluntary and the authors have not been remunerated for their contributions. There was no direct industry involvement in the development or dissemination of this guideline. CancerControl Alberta recognizes that although industry support of research, education and other areas is necessary in order to advance patient care, such support may lead to potential conflicts of interest. Some members of the Alberta Provincial Head and Neck Tumour Team are involved in research funded by industry or have other such potential conflicts of interest. However the developers of this guideline are satisfied it was developed in an unbiased manner.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180712204003/https://www.guideline.gov/Home/Disclaimer?id=48140&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.albertahealthservices.ca%2fassets%2finfo%2fhp%2fcancer%2fif-hp-cancer-guide-hn003-nasopharyngeal.pdf" title="Alberta Health Services Web site">Alberta Health Services Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712204003im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following is available:</p>
<ul style="list-style-type: disc;">
    <li>Guideline utilization resource unit handbook. Edmonton (Alberta): CancerControl Alberta; 2013 Jan. 5 p. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on August 12, 2014. The information was verified by the guideline developer on September 25, 2014. This summary was updated by ECRI Institute on February 15, 2017 following the U.S. Food and Drug Administration advisory on general anesthetic and sedation drugs.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712204003/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712204003/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712204003/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204003/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204003/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204003/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204003/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712204003/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712204003/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712204003/https://www.guideline.gov/disclaimer?id=48140&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712204003/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712204003/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712204003/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712204003/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712204003/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712204003/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712204003/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712204003/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712204003/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712204003/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712204003/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712204003/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712204003/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712204003im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712204003/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712204003/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712204003js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712204003js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:40:03 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:57:22 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 506.281 (3)
  esindex: 0.013
  captures_list: 551.363
  CDXLines.iter: 31.274 (3)
  PetaboxLoader3.datanode: 452.546 (4)
  exclusion.robots: 0.169
  exclusion.robots.policy: 0.159
  RedisCDXSource: 8.168
  load_resource: 52.459
-->